| Plasma agriculture: Review from the perspective of the plant and its ecosystem P Ranieri, N Sponsel, J Kizer, M Rojas‐Pierce, R Hernández, L Gatiboni, ... Plasma Processes and Polymers 18 (1), 2000162, 2021 | 172 | 2021 |
| Effects of cold plasma treatments on spot-inoculated Escherichia coli O157: H7 and quality of baby kale (Brassica oleracea) leaves U Shah, P Ranieri, Y Zhou, CL Schauer, V Miller, G Fridman, JK Sekhon Innovative Food Science & Emerging Technologies 57, 102104, 2019 | 49 | 2019 |
| Measuring plasma-generated· OH and O atoms in liquid using EPR spectroscopy and the non-selectivity of the HTA assay B Myers, P Ranieri, T Smirnova, P Hewitt, D Peterson, MH Quesada, ... Journal of Physics D: Applied Physics 54 (14), 145202, 2021 | 44 | 2021 |
| GSH modification as a marker for plasma source and biological response comparison to plasma treatment P Ranieri, H Mohamed, B Myers, L Dobossy, K Beyries, D Trosan, ... Applied Sciences 10 (6), 2025, 2020 | 27 | 2020 |
| Microsecond-Pulsed Dielectric Barrier Discharge Plasma-Treated Mist for Inactivation of Escherichia coli In Vitro P Ranieri, G McGovern, H Tse, A Fulmer, M Kovalenko, G Nirenberg, ... IEEE Transactions on Plasma Science 47 (1), 395-402, 2018 | 17 | 2018 |
| Following O and OH in He/O2 and He/H2O gas mixtures—From the gas phase through the liquid phase to modifications on a biological sample K Stapelmann, B Myers, MH Quesada, E Lenker, PJ Ranieri Journal of Physics D: Applied Physics 54 (43), 434003, 2021 | 15 | 2021 |
| Nanosecond-pulsed dielectric barrier discharge–induced antitumor effects propagate through depth of tissue via intracellular signaling P Ranieri, R Shrivastav, M Wang, A Lin, G Fridman, AA Fridman, LH Han, ... Plasma medicine 7 (3), 2017 | 15 | 2017 |
| Non-thermal plasma treatment of flowing water: A solution to reduce water usage and soil treatment cost without compromising yield J Brar, J Jiang, A Oubarri, P Ranieri, AA Fridman, G Fridman, V Miller, ... Plasma Medicine 6 (3-4), 2016 | 12 | 2016 |
| Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma V Batra, M Samanta, M Makvandi, D Groff, P Martorano, J Elias, P Ranieri, ... Clinical Cancer Research 28 (18), 4146-4157, 2022 | 11 | 2022 |
| Real-time monitoring of intracellular chemical changes in response to plasma irradiation A Ray, P Ranieri, L Karamchand, B Yee, J Foster, R Kopelman Plasma Medicine 7 (1), 2017 | 11 | 2017 |
| Optimization of short-pulsed dielectric barrier discharge for in-package disinfection P Ranieri, A Mannsberger, C Liu, A Suarez, NA Huynh, V Miller, ... Plasma Medicine 8 (2), 2018 | 2 | 2018 |
| Development of meta-[211At] astatobenzylguanidine ([211At] MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma V Batra, P Ranieri, M Makvandi, M Tsang, C Hou, Y Li, G Vaidyanathan, ... Cancer Research 75 (15_Supplement), 1610-1610, 2015 | 2 | 2015 |
| Circumcision Device and Procedure RM Johnson, P Ranieri, K Chrouser, S Green US Patent App. 13/114,692, 2012 | 2 | 2012 |
| Meta-[211At]astatobenzylguanidine ([211At]MABG) is a potent alpha particle emitting systemic targeted radiotherapeutic in preclinical models of neuroblastoma V Batra, J Elias, M Makvandi, M Tsang, P Ranieri, C Hou, Y Li, DA Pryma, ... Cancer Research 77 (13_Supplement), 688-688, 2017 | 1 | 2017 |
| Exploring chemical modifications caused by the COST-Jet in NO-rich gas admixtures by means of FTIR and Mass Spectrometry on the simple biological model cysteine M Herrera Quesada, P Ranieri III, K Stapelmann APS Annual Gaseous Electronics Meeting Abstracts, MR12. 003, 2021 | | 2021 |
| Modified GSH embedded in gelatin elucidates the penetration depth of COST-Jet generated reactive species P Ranieri, D Trosan, K Stapelmann APS Annual Gaseous Electronics Meeting Abstracts, PW4. 002, 2020 | | 2020 |
| Hydroxyl radical densities in plasma treated liquid B Myers, P Ranieri, K Stapelmann APS Annual Gaseous Electronics Meeting Abstracts, MW1. 073, 2019 | | 2019 |
| Plasma Transfer Processes in Medical and Agricultural Applications PJ Ranieri III Drexel University, 2018 | | 2018 |
| Inhibition of exportin 1 (XPO1) by selinexor (KPT-330) synergistically suppresses growth of neuroblastoma in combination with doxorubicin or bromodomain inhibition PJ Ranieri, R Trillo, Y Landesman, W Senapedis, D McCauley, ... Cancer Research 75 (15_Supplement), 501-501, 2015 | | 2015 |
| Preclinical development of Meta-[211At] astatobenzylguanidine ([211At] MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma (NB). V Batra, M Makvandi, P Ranieri, M Tsang, C Hou, Y Li, G Vaidyanathan, ... Journal of Nuclear Medicine 56 (supplement 3), 1264-1264, 2015 | | 2015 |
